This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Gastroenterology
One-year results for biosimilar infliximab switching study in Crohn’s disease
Read more
Symptom improvement in moderately to severely active Crohn’s disease with ustekinumab
Read more
Guideline for the management of nut allergy helps to define diagnostic pathways, including the role of specific IgE testing
Read more
Eluxadoline receives final approval from NICE for the treatment of IBS with diarrhoea
Read more
Biosimilar adalimumab and infliximab accepted for regulatory review by the EMA
Read more
Treating paediatric short bowel syndrome
Read more
Use of extended-pulsed regimen with fidaxomicin more effective than standard vancomycin in CDI
Read more
NICE recommends Stelara for moderate to severe Crohn’s disease
Read more
Biologics and biosimilars in IBD
Read more
Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review
Read more
New statement supports switching to biosimilar from reference product in IBD
Read more
Results from NOR-SWITCH study support switch from Remicade® to Remsima®
Read more
Janssen receives CHMP positive opinion for Stelara® for moderately to severely active Crohn’s disease
Read more
PENTAX Medical introduces new high definition video processor for gastrointestinal endoscopic imaging
Read more
Merck partners with Array BioPharma and Pierre Fabre to initiate BRAF-mutant CRC trial
Read more
New faecal bank offers unusual cure
Read more
Almost half of patients with UC using conventional therapies are dissatisfied with their treatments
Read more
Page 10 of 12
« First
«
...
8
9
10
11
12
»
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: